Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 4 , Pages 513-523, August 2009

Incretin-based therapy: how do incretin mimetics and DPP-4 inhibitors fit into treatment algorithms for type 2 diabetic patients?

  • M. Nauck (Prof. Dr. med.)

      Affiliations

    • Diabeteszentrum Bad Lauterberg, Kirchberg 21, D-37431 Bad Lauterberg im Harz, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 5524 81218; Fax: +49 5524 81398.
    • ,
  • U. Smith, MD, PhD

      Affiliations

    • Department of Internal Medicine, University of Gothenburg, Sweden

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(09)00021-9

doi:10.1016/j.beem.2009.03.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 4 , Pages 513-523, August 2009

Article Tools

* Image Usage & Resolution